Healthy high growth potential

Results

1488

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1488 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
ADMR
Rp1,365.00-10.8%36.5%Rp55.8tRp2,418.0210.627.7%3.4%Materials
9218
JP¥710.001.3%0.3%JP¥7.5bn/a31.328.9%1.4%Healthcare
456A
JP¥1,510.004.4%n/aJP¥138.4bn/a42.723.4%n/aRetail
SAATVIKGL
₹462.40-1.0%n/a₹58.8b₹520.0016.448.8%n/aSemiconductors
2315
HK$46.8812.5%108.4%HK$48.0bHK$62.0262.540.4%n/aPharmaceuticals & Biotech
1357
HK$3.78-7.8%-58.1%HK$17.2bHK$9.3220.331.4%2.6%Media
2368
NT$1,155.00-17.2%291.5%NT$583.7bNT$1,485.0051.538.2%0.9%Tech
3881
HK$21.40-3.7%n/aHK$9.4bn/a9.2107.6%n/aCapital Goods
001389
CN¥220.4914.8%275.2%CN¥101.9bCN¥248.6789.232.2%0.3%Tech
002384
CN¥249.59-7.7%560.8%CN¥454.9bCN¥157.50223.073.1%0%Tech
MONOLITH
₹774.406.8%167.6%₹16.8b₹960.0073.137.2%n/aMaterials
301345
CN¥230.637.6%113.3%CN¥25.1bCN¥320.3527.731.5%1.3%Automobiles
SCHNEIDER
₹1,453.604.2%74.6%₹347.6b₹1,230.00163.534.0%n/aCapital Goods
2480
HK$12.810.2%-47.0%HK$2.5bHK$31.003.377.1%n/aPharmaceuticals & Biotech
6990
HK$435.6011.0%33.1%HK$101.6bHK$547.6442.844.8%n/aPharmaceuticals & Biotech
VIKRAMSOLR
₹186.68-5.8%n/a₹67.6b₹246.6014.430.0%n/aSemiconductors
MIDWESTLTD
₹1,245.30-4.2%n/a₹45.0b₹1,500.0042.959.3%n/aMaterials
EIEL
₹219.46-2.4%-7.3%₹38.5b₹346.0021.137.8%n/aCapital Goods
6787
JP¥31,650.00-14.6%365.4%JP¥812.4bJP¥26,066.6741.727.3%0.5%Tech
1860
HK$10.50-12.8%47.9%HK$16.1bHK$18.2627.641.1%n/aMedia
688192
CN¥40.708.3%-31.9%CN¥18.9bCN¥83.0021.2105.9%n/aPharmaceuticals & Biotech
325
HK$42.54-6.5%-69.9%HK$10.6bHK$81.0014.422.7%n/aConsumer Durables
MX1
AU$0.031-16.2%-36.7%AU$23.2mAU$0.151.4105.5%n/aHealthcare
501423
₹2,897.454.9%74.3%₹133.3b₹3,517.6778.433.7%0.1%Capital Goods
Page 1 of 42